About
Dynavax Technologies is a commercial-stage biopharmaceutical company that develops and commercializes vaccines and immunotherapy products using toll-like receptor agonists as adjuvants to enhance immune responses.
Explore Dynavax Technologies's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.